ArticleACG case reports journal2026

Dual-Targeted Therapy With Upadacitinib and Ustekinumab in Pediatric Refractory Perianal Crohn's Disease.

Neha Sathe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.